PEDIATRICS Vol. 65 No. 3 March 1980, pp. 680
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nelson, K. B.
Right arrow Articles by Ellenberg, J. H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Nelson, K. B.
Right arrow Articles by Ellenberg, J. H.

Letters to the Editor

Karin B. Nelson MD1 and Jonas H. Ellenberg PhD2

1 Developmental Neurology Branch
2 Office of Biometry and Epidemiology, National Institute of Neurological and Communicative Disorders and Stroke, National Institutes of Health, Bethesda, MD 20205

The sources of information concerning treatment of febrile seizures in our recent study were medical records written at the time of treatment of an initial or later febrile seizure, the nine scheduled interval histories, and a full history of the child's medical experience recorded when registrants reached the age of 7 years. However, information on drug usage, unlike the remainder of the information utilized in these studies, was not based upon structured portions of the questionnaires and was not systematically available for all registrants.